-
MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China
07 Jun 2024 10:48 GMT
… antibacterial drug.
China Phase I Clinical Trial Results
The Phase I clinical trial in … US and China Phase I clinical trials to formulate … from the Phase I clinical trial completed in the … phase-i-clinical-trial-for-self-developed-mrx-8-antibacterial-drug …
-
Antibody-Drug Conjugates In Oncology Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Companies By Delveinsight
07 Jun 2024 12:27 GMT
… from the Phase I/II clinical trial for breast cancer and the Phase I clinical trial for … ADC Therapeutics
Phase I
Solid tumors
ADCT-901
ADC Therapeutics
Phase I
Solid … clinical development @
Antibody-drug Conjugates in Clinical Trials
Table of Contents
1 …
-
MicuRx’s Phase I trial of antibacterial drug meets expected goals
07 Jun 2024 11:22 GMT
… successful conclusion of the Phase I clinical trial of its antibacterial drug MRX-8 in … components, aimed to assess the drug’s safety, tolerability, and … from both US and China Phase I trials to advance MRX-8 … to the data from a Phase I trial completed in the …
-
MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease
07 Jun 2024 08:25 GMT
… novel drug to treat Alzheimer's disease (AD), enabling a Phase 1 clinical trial … for AD Clinical Trials TML-6 is developed as an oral drug and … will conduct a SAD/MAD phase 1 clinical trial at …
-
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
06 Jun 2024 11:30 GMT
… enabling preclinical studies.” AEROW Clinical Trial Phase 1 Dose Exploration Stage Background … eligibility and/or drug intolerance). In people with … Disease Designation and Orphan Drug Designation from the U … .S. Food and Drug Administration (FDA). About …
-
CTLA-4 Inhibitors Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Companies By Delveinsight
07 Jun 2024 02:12 GMT
… therapies, analysis of Clinical Trials, Therapies, Mechanism … Drug (IND) application, allowing the commencement of a Phase I/II clinical trial … 47;university websites, clinical trial registries, conferences, SEC … Assessment and clinical trials @ CTLA- …
-
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China
07 Jun 2024 00:00 GMT
… announces that it has initiated Phase I clinical trial of its menin inhibitor … , 2024.
This is a Phase I, multicenter, open-label clinical … focused on bringing cancer drug candidates from in-house … with its first three oncology drugs marketed in China, the …
-
Anorexia Nervosa Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Companies By Delveinsight
07 Jun 2024 00:10 GMT
… the Anorexia Nervosa Clinical Trial Activities and Regulatory … drug candidates to the most advanced stage of clinical trials, … )
Early-stage product (Phase I)
Pre-clinical and Discovery … Perspectives @ Anorexia Nervosa Clinical Trials and FDA Approvals
Table …
-
FDA Grants Orphan Drug Designation to AGMB-447 for Idiopathic Pulmonary Fibrosis
08 Jun 2024 00:04 GMT
About the Trial
Trial Name: Phase I Study to Assess Safety, Tolerability, … ). Currently, the investigational drug is being evaluated in a phase 1 clinical trial (NCT06181370) to … /20240606970963/en
2. Phase I Study to Assess Safety, Tolerability …
-
Phase 1 Study Findings Support Efficacy of ALTO-101 for the Treatment of Cognitive Impairment in Schizophrenia
06 Jun 2024 19:47 GMT
… animal models and early clinical trials exploring treatments for cognitive … double-blind, placebo-controlled phase 1 trial including 40 healthy … positive results highlight the drug’s potential and … a randomized, double-blind phase 1 study. Poster presentation. …